Birmingham
Birmingham ECMC aims to improve the feasibility and quality of research in the areas of immunotherapy and gene therapy, translational genetics and biomarkers. This is being conducted in many different types of cancer. The Centre has established bio-repositories, developed antibody-based assays and conducted various immunotherapy/gene therapy trials.
Clinical Focus Area
- Medical oncology
- Surgery
- Cancer prevention
- Haemato-oncology
Scientific Focus Area
- Cancer epigenetics
- Angiogenesis
- DNA damage and repair
- Virus associated oncogenesis
- Cancer immunology
Disease Focus
| Bladder | Colorectal | Leukaemia | Liver |
| Melanoma | Myeloma | Non-Hodgkins Lymphoma | Oesophageal |
| Pancreatic | Prostate | Sarcoma | Vulvar |
Birmingham ECMC principal investigators and staff have a range of skills and expertise.
Birmingham ECMC has access to a range of research facilities that are utilised in studies.
Increase text size
Decrease text size
Print page